Anavex Life Sciences (NASDAQ:AVXL) executives used the company’s fiscal 2026 first-quarter earnings call to outline regulatory next steps for oral blarcamesine in early Alzheimer’s disease and to revi ...
Thank you, Clint, and good morning, everyone. As we enter 2026, we continue to progress our innovative clinical pipeline with a particular focus on our lead candidate, oral blarcamesine, in early ...
If Windows ever has trouble launching, Recovery Drive lets you back up essential system files to an external USB drive to help Windows boot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results